Latest filing published 26 Apr 2021 for Neogenomics INC, €51k.
Filing timeline
BuySaleInsider track record
Lawrence Martin Weiss: trading record in brief
Lawrence Martin Weiss is a declared insider of Neogenomics Inc, with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 1 March 2019 and the latest from 22 April 2021.
On the market, this insider has only sold: 1 sale, €850k in total. Outside the open market, there are 3 share grants and 8 option exercises.
On 26 April 2021 came the latest disclosure, an option exercise for €221k in Neogenomics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lawrence Martin Weiss
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,667 shares@ US$9.222.4% of flowCommon StockSEC:0001077183-21-000113:0
- 9,005 shares@ US$19.606.9% of flowCommon StockSEC:0001077183-21-000113:1
- 9,378 shares@ US$28.3310.5% of flowCommon StockSEC:0001077183-21-000113:2
- 5,276 shares0Common StockSEC:0001077183-21-000079:0
- 50,000 shares@ US$6.9817.0% of flowCommon StockSEC:0001077183-20-000227:0
- 20,000 shares@ US$7.277.1% of flowCommon StockSEC:0001077183-20-000227:1
- 13,333 shares@ US$9.226.0% of flowCommon StockSEC:0001077183-20-000227:2
- 16,666 shares@ US$13.8711.2% of flowCommon StockSEC:0001077183-20-000227:3
- 9,005 shares@ US$19.608.6% of flowCommon StockSEC:0001077183-20-000227:4
- 20,200 shares@ US$51.0650.2% of flowCommon StockSEC:0001077183-20-000227:5
- 5,824 shares0Common StockSEC:0001077183-20-000033:0
- 5,893 shares0Common StockSEC:0001077183-19-000025:0
12 of 12 declarations
